Barbara Altieri

Also affiliated with Universitätsklinikum Würzburg

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “PLK1 inhibitors as a new targeted treatment for adrenocortical carcinoma”.

PLK1 inhibitors as a new targeted treatment for adrenocortical carcinoma

Endocrine Abstracts(2021)10.1530/endoabs.77.op2.3

N/A

0DataRank · unranked

0 citations

Gabrielle Smith, Vasileios Chortis, Sana Khan, Juliane Lippert, Constanze Hantel +8 more

Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study

The Lancet Diabetes & Endocrinology(2022)10.1016/s2213-8587(22)00100-0

N/A

0DataRank · unranked

184 citations

Giuseppe Reimondo, Guido Di Dalmazi, Irina Bancos, Jekaterina Patrova, Dimitra A. Vassiliadi +55 more

Present and Future of Personalised Medicine for Endocrine Cancers

Directory of Open access Books (OAPEN Foundation)(2022)10.3390/books978-3-0365-4329-1

N/A

0DataRank · unranked

1 citations

Barbara Altieri, Cristina L. Ronchi

PLK1 inhibitors as a new targeted treatment for adrenocortical carcinoma

Endocrine Connections(2023)10.1530/ec-23-0403

N/A

0DataRank · unranked

5 citations

Gabrielle Smith, Vasileios Chortis, Raimunde Liang, Juliane Lippert, Sonja Steinhauer +8 more